Navigation Links
Kendle Appoints Martha Feller, PhD, Vice President and Global Head, Study Start-up
Date:2/28/2011

CINCINNATI, Feb. 28, 2011 /PRNewswire/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization (CRO), today announced Martha R. Feller, PhD, has rejoined the Company as Vice President and Global Head, Study Start-up, effective immediately. Dr. Feller brings to Kendle more than 30 years of senior operations leadership in the clinical development industry, including broad therapeutic expertise and vast experience in managing large-scale, multimillion-dollar global development programs. In her new role Dr. Feller will provide leadership for the Company's global Study Start-up function – including Study Start-up Management, Site Identification, Site Start-up, Clinical Trial Regulatory, Investigator Contracts and Essential Document Collection – and will focus on fostering strong site relationships to optimize timelines and deliver rapid study start-up for global clinical trials.

"Timely and efficient study start-up on global projects is essential to our business success and ability to deliver best-in-class clinical development solutions to our customers," said Stephen Cutler, PhD, Senior Vice President and Chief Operating Officer. "The appointment of an experienced industry veteran to lead this important function demonstrates our commitment to delivery of site selection and start-up strategies that provide valuable time-saving results for our customers."

Dr. Feller rejoins Kendle following two years with i3 Research where she served as Executive Vice President, Global Operations responsible for Phase I-III clinical programs. From 2004 to 2009 Dr. Feller held leadership roles in Kendle's Phase II-III clinical development operations, serving most recently as Senior Vice President, Global Clinical Development. Prior to joining Kendle, she spent 24 years with Procter & Gamble Pharmaceuticals where she held several senior-level pos
'/>"/>

SOURCE Kendle International Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Kendle Announces CEO Succession Plan, Promotes Stephen Cutler, PhD, to President and CEO
2. Kendle to Present at Lazard Capital Markets 7th Annual Healthcare Conference
3. Kendle Announces Details Regarding Third Quarter 2010 Earnings Conference Call and Webcast
4. Kendle Appoints Mark J. Roseman, D.Sc., Senior Vice President and Chief Marketing Officer
5. Kendle Announces Details Regarding Second Quarter 2010 Earnings Conference Call and Webcast
6. Kendle to Present at 2010 Wells Fargo Securities Healthcare Conference
7. Kendle Advances Early Stage Drug Development with ElMindAs Innovative Brain Network Activation Technology
8. Kendle Director of Global Safety and Pharmacovigilance, Drew Kilpatrick, PhD, Named One of Ten Notable People in R&D
9. Kendle Executive to Share Insights at World Pharma Trials Asia 2010
10. Kendle is First Global CRO to Achieve ISO 9001:2008 Certification in China Through Beijing Affiliate
11. Kendle Launches New Global Biostatistics Infrastructure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... SOUTH SAN FRANCISCO, Calif. , March 2, ... therapeutics for the treatment of cancer, today announced ... comprised of leading researchers and clinicians in the ... The new advisory boards will ... its wholly owned pipeline of precision immunotherapies and ...
(Date:3/2/2015)... , March 2, 2015   Mast ... biopharmaceutical company, today announced preliminary findings from a ... a model of chronic, stable heart failure produced ... study was to examine the effects of repeat ... systolic and diastolic function. Consistent ...
(Date:3/2/2015)... 2015  Delcath Systems, Inc. (NASDAQ: DCTH ... on oncology with an emphasis on the treatment of ... will participate in the upcoming 27 th Annual ... the Ritz Carlton Laguna Niguel in Dana ... MSN, CRNP, Delcath,s interim President and Chief Executive Officer, ...
Breaking Medicine Technology:CytomX Expands Scientific and Clinical Advisory Boards with Leading Experts in Cancer Immunotherapy and Antibody Drug Conjugates 2CytomX Expands Scientific and Clinical Advisory Boards with Leading Experts in Cancer Immunotherapy and Antibody Drug Conjugates 3Mast Announces Results From Nonclinical Study Investigating Repeat Treatment With Vepoloxamer In Advanced Heart Failure 2Mast Announces Results From Nonclinical Study Investigating Repeat Treatment With Vepoloxamer In Advanced Heart Failure 3Mast Announces Results From Nonclinical Study Investigating Repeat Treatment With Vepoloxamer In Advanced Heart Failure 4Mast Announces Results From Nonclinical Study Investigating Repeat Treatment With Vepoloxamer In Advanced Heart Failure 5Mast Announces Results From Nonclinical Study Investigating Repeat Treatment With Vepoloxamer In Advanced Heart Failure 6Delcath To Present At The 27th Annual Roth Conference 2Delcath To Present At The 27th Annual Roth Conference 3
... The Epilepsy Foundation recently announced findings that show ... a consistent drug therapy, have a greater chance of ... their medications are switched from one version of an ... brand-to-generic, generic-to-brand or generic-to-generic. See video from the Epilepsy ...
... Findings Reinforce March of Dimes Message: Start Taking a ... 11 Women who take folic acid supplements for ... cut their risk of having a premature baby by ... online journal, PLOS Medicine.The study links pre-conceptional folate supplementation ...
Cached Medicine Technology:VIDEO from Medialink and the Epilepsy Foundation: New Study Suggests Different Versions of the Same Epilepsy Medication Can Be Harmful 2Taking Folic Acid for a Year Before Pregnancy May Reduce Risk of Preterm Birth 2
(Date:3/2/2015)... YORK, NY (PRWEB) March 02, 2015 This ... off March 2–8 and will provide opportunities for people across ... new ways to help people with MS live their best ... progress made and to inspire others to join the Society’s ... Multiple sclerosis, an unpredictable, often disabling disease of the central ...
(Date:3/2/2015)... March 02, 2015 Atlantic Information Services, ... AIS’s Directory of Health Plans: 2015 , the ... on the U.S. health plan market, with enrollment data ... United States. , Available as a printed book ... enrollment trends in quick-view tables and charts, as well ...
(Date:3/2/2015)... Quinta, CA (PRWEB) March 02, 2015 A ... Trades”—Jack Eadon, leader of the 1960s cult rock band Khazad ... fueled by his determination to persevere despite all odds. His ... It,” no matter what situation or goal was before him. ... the ’60s, is now being passed on to a new ...
(Date:3/2/2015)... The Alliance for Bangladesh Worker Safety today announced ... serve as chief safety officer. In this role, he ... and guide remediation efforts in all factories from which ... the Alliance continues to bring world-class expertise to factory ... said Alliance Independent Chair Ellen Tauscher. “His role as ...
(Date:3/2/2015)... 2015 Éminence Organic Skin Care, the ... excited to announce the launch of the Balance Collection, ... time-saving solution for those with combination skin. The Balancing ... divided jar to separate the products, consists of the ... Balancing Moisturizer Duo, also in a divided jar, contains ...
Breaking Medicine News(10 mins):Health News:Every Connection Counts During MS Awareness Week 2Health News:Every Connection Counts During MS Awareness Week 3Health News:Every Connection Counts During MS Awareness Week 4Health News:Now Available from AIS: 12th Edition of Annual Book Containing Health Plan Enrollment Data, Contact Information 2Health News:Cult Rock Star’s “Got To Make It” Attitude Inspires New Generations 2Health News:Cult Rock Star’s “Got To Make It” Attitude Inspires New Generations 3Health News:Alliance for Bangladesh Worker Safety Names New Chief Safety Officer 2Health News:Éminence Organic Skin Care Launches Innovative Collection for Combination Skin 2Health News:Éminence Organic Skin Care Launches Innovative Collection for Combination Skin 3
... care trends seeking to advance "individualized medicine" are private ... kits, with price tags as high as $2,500, use ... human genome (called "single nucleotide polymorphisms" or "SNPs") associated ... prostate cancer. The U.S. Food and Drug Administration ( ...
... patients are given the choice, they are significantly more likely ... of life six months after treatment, compared to a paper ... session, October 5, 2011, at the 53rd Annual Meeting of ... challenges the perception that older cancer patients do not have ...
... California, San Diego have developed what they believe to ... biologically benign levels of near infrared (NRI) irradiation, enabling ... The study represents a significant milestone in the area ... Their work is published on line this week ...
... Beach, Fla., October 2, 2011 While the majority (70 ... bereaved family and caregivers of their patients who have died, ... in this area during their residency or fellowship, according to ... Meeting of the American Society for Radiation Oncology (ASTRO). , ...
... via the Internet may make it easier for cancer patients ... a study conducted by researchers in the Perelman School of ... at the American Society for Radiation Oncology,s (ASTRO) 53rd Annual ... potential way to buoy the low percentage of adult cancer ...
... 2011 The Children,s Hospital of Eastern Ontario (CHEO) ... its principal investigators in infectious disease has signed a ... company headquartered in Carlsbad, California, to share information that ... detect the DNA coding for infectious diseases. Dr. Robert ...
Cached Medicine News:Health News:Study gauges emotional toll of direct-to-consumer genetic testing 2Health News:Cancer patients in their 60s are tech-savvy 2Health News:Polymeric material has potential for noninvasive procedures 2Health News:Most cancer physicians reach out to bereaved family, caregivers 2Health News:Penn-developed online informed consent tool could boost number of patients in cancer clinical trials 2Health News:Global biotech firm partners with CHEO researcher to address a technology gap in infectious disease 2
Created to simplify stereopsis screening in children. Based on principles of random dots. No glasses are necessary for this stereo test, and the child's eye movement can be easily observed....
... versatile new test providing the broadest range ... The Multi-Target Stereo test can be used ... stereopsis, visual attention, form and depth perception, ... includes a pair of high quality reversible ...
... These polarized stereo tests provide ... come with a choice of polarized ... thick film lenses slipped into a ... The other choice includes Richmonds new ...
Comes with seven test plates. Red and green glasses filters are mounted in two frames, one for adults and one for children. Suitable for testing very small children as well as adults....
Medicine Products: